NEW YORK – August 17, 2026 (STL.News) Investors in Embecta Corp. (NASDAQ: EMBC) face a Monday deadline to seek appointment as lead plaintiff in a federal securities class action alleging the medical device company and certain executives made materially false or misleading statements concerning its financial outlook and the strength of its U.S. pen needle business. The lawsuit, Apitz-Grossman v. Embecta Corp., et al., Case No. 2:26-cv-07217, was …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.